Targeted Therapies
Targeted therapies are a type of treatment that involves the use of drugs and other medications to specifically identify and attack cancerous cells. Unlike traditional treatments, targeted therapies also aim to minimize damage to normal, healthy cells. These therapies work by reprogramming the inner machinery of cancerous cells, disrupting their growth, division, and spread. The specific side effects of targeted therapies vary depending on the drug used. In some cases, targeted therapies may be recommended alongside chemotherapy, while in other cases they may be used as a standalone treatment. One example of a targeted therapy is angiogenesis inhibitors.
Understanding PARP Inhibitors for Cancer Treatment
Poly (ADP)-ribose polymerase (PARP) inhibitors are a class of drugs that play a crucial role in repairing abnormal DNA within cells. Additionally, they are known to impede the ability of tumor cells with mutated genes to restore their damaged DNA. This makes PARP inhibitors particularly effective in treating advanced ovarian cancer.
Typically, PARP inhibitors are recommended after chemotherapy has been attempted due to the invasive nature of the treatment regimen. However, studies have shown that ovarian cancers associated with certain gene mutations respond favorably to PARP inhibitors.
Notably, PARP inhibitors have been successfully tested in patients with various types of BRCA gene mutations. To determine if you are a suitable candidate for PARP inhibitors, your doctor can order a simple blood test.